We are live on ! Find out more
TSV

Two Sigma Ventures Portfolio holdings

AUM $9.61M
1-Year Est. Return 58.41%
This Fund
S&P 500
This Quarter Est. Return
-28.58%
1 Year Est. Return
-58.41%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.4M
AUM Growth
–
Cap. Flow
+$59.7M
Cap. Flow %
118.38%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RXRX icon
Recursion Pharmaceuticals
RXRX
+$34M
2
ZY
Zymergen Inc. Common Stock
ZY
+$14.7M
3
GTLB icon
GitLab
GTLB
+$11M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 81.47%
2 Technology 18.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.84B
$30.9M 61.39%
+1,806,800
New +$34M
ZY
2
DELISTED
Zymergen Inc. Common Stock
ZY
$10.1M 20.09%
+1,513,727
New +$14.7M
GTLB icon
3
GitLab
GTLB
$7.57B
$9.34M 18.53%
+107,357
New +$11M

Similar funds

CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
AG
AlphaSimPlex Group Boston, Massachusetts $9.88M AUM 8.01% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
PL
Portland Ltd Grand Cayman, Cayman Islands $10.9M AUM 72.34% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
LGI
Lakestar Growth I St. Peter Port, Guernsey $11.5M AUM 71.31% 1-Year Est. Return

Two Sigma Ventures's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Two Sigma Ventures, which disclosed 3 positions worth $50.4M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Recursion Pharmaceuticals: 1,806,800 shares worth $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, followed by Technology.

  • Two Sigma Ventures's largest Q4 2021 buy was Recursion Pharmaceuticals: 1,806,800 shares worth $30.9M.
  • Two Sigma Ventures's ten largest holdings make up 100% of its $50.4M portfolio in Q4 2021.
  • Two Sigma Ventures disclosed 3 positions in Q4 2021, its first 13F filing on record.

Based on Two Sigma Ventures's 13F filing for Q4 2021, filed 14 Feb 2022.